|Articles|August 1, 2017
- BioPharm International-08-01-2017
- Volume 30
- Issue 8
BioPharm International, August 2017 Issue (PDF)
Click the title above to open the BioPharm International August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Gottlieb Tackles Opioids, Drug Costs, and Innovationover 8 years ago
CDMOs: New Administration, New Frontierover 8 years ago
Just the Biopharma Facts, Pleaseover 8 years ago
Process Chromatography: Continuous Optimizationover 8 years ago
Optimizing Cell-Culture Mediaover 8 years ago
Keeping it Clean: Biopharmaceutical Cleaning Validationover 8 years ago
The Role of Quality Standards for Biomanufacturing Raw Materialsover 8 years ago
Avoiding Investigational Failures and Discrepanciesover 8 years ago
Analytical Strategy in the Development of BiosimilarsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
